KEY FINDINGS
The United States hormone replacement therapy market is expected to register a CAGR of 7.62% during the forecast period, 2021-2026. There are high prevalence rates of hormonal disorders like hypoparathyroidism, hypogonadism, hypothyroidism, etc. With hypothyroidism at 80% prevalence in the iodine-deficient population.
MARKET INSIGHTS
In the US, congenital cases in newborns and adult hypothyroidism are set to drive market growth. As per the Boston University School of Medicine study, around 60% of the elderly population needs hormone replacement therapy (HRT) to prevent libido, energy loss, and erectile dysfunction.
Further, the dissimilarities in HRT use with age are associated with the type of menopause. Compared to women below 45, those between 45 and 54 were more likely to have used HRT. At the same time, there was no major difference in HRT use between surgically menopausal women aged less than 45 and those aged 65 and above.
As per the studies carried out by agencies like the North America Menopause Society (NAMS) and Rose Research, almost 1 million women in the US are opting for HRT. As a result, the increasing number of women reaching menopause is estimated to lead the market growth.
COMPETITIVE INSIGHTS
Some of the eminent companies in the market are Noven Pharmaceuticals Inc, Pfizer Inc, ANI Pharmaceuticals, Abbott Laboratories, etc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments